ULSUL Solutions Inc.
Services-Testing Laboratories
- Revenue
- $3.1B
- 6.4% YoY
- Operating margin
- 17.1%
- 6.2% YoY
- EBITDA
- $710M
- 12% YoY
- Market cap
- $15.0B
- Employees
- 14,587
- $209K revenue each
- Net debt / EBITDA
- 0.1×
- $57M net debt
- AI in 10-K
- 7.7
- mentions per 10K words
Takeover score 2 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo185% of net incomeCash flow under 80% of net income
- Dilutive SBCNo2% of revenueOver 10% of revenue
- Payouts exceed cash flowNo17% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo21% of assetsOver 40% of assets
- Shareholder dissentNo100% lowest supportAny vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeYes$209K · 24th pctBottom quartile of its SIC industry
- Quiet on AINo7.7 per 10K words · 89th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo0.1× EBITDA net debtMore cash than debt, positive EBITDA
- Buyout-sizedNo$15.0B market capMarket cap $500M–$5B
Catalysts 1 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingYes−$1.1B netNet sales over $10M in 12 months
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.9B | $3.1B | 6.4% |
| Operating income | $412M | $368M | $462M | $522M | 13% |
| Net income | $293M | $260M | $326M | $325M | 0.3% |
| Operating cash flow | $372M | $467M | $524M | $600M | 15% |
| Capex | $164M | $215M | $237M | $197M | 17% |
| Stock-based comp | $0 | $0 | $23M | $47M | 104% |
| Dividends | $1.6B | $680M | $100M | $104M | 4.0% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $3K · 2
- Open-market sells, 12 mo
- $1.1B · 26
- Net
- −$1.1B
Pay vs performance
No pay-versus-performance disclosure yet.